BACKGROUND: Comparative effectiveness research (CER) is intended to inform decision making in clinical practice, and is central to patient-centered outcomes research (PCOR). PURPOSE: To summarize key aspects of CER definitions and provide examples highlighting the complementary nature of efficacy and CER studies in pulmonary, critical care, and sleep medicine. METHODS: An ad hoc working group of the American Thoracic Society with experience in clinical trials, health services research, quality improvement, and behavioral sciences in pulmonary, critical care, and sleep medicine was convened. The group used an iterative consensus process, including a review by American Thoracic Society committees and assemblies. RESULTS: The traditional efficacy paradigm relies on clinical trials with high internal validity to evaluate interventions in narrowly defined populations and in research settings. Efficacy studies address the question, "Can it work in optimal conditions?" The CER paradigm employs a wide range of study designs to understand the effects of interventions in clinical settings. CER studies address the question, "Does it work in practice?" The results of efficacy and CER studies may or may not agree. CER incorporates many attributes of outcomes research and health services research, while placing greater emphasis on meeting the expressed needs of nonresearcher stakeholders (e.g., patients, clinicians, and others). CONCLUSIONS: CER complements traditional efficacy research by placing greater emphasis on the effects of interventions in practice, and developing evidence to address the needs of the many stakeholders involved in health care decisions. Stakeholder engagement is an important component of CER.
BACKGROUND: Comparative effectiveness research (CER) is intended to inform decision making in clinical practice, and is central to patient-centered outcomes research (PCOR). PURPOSE: To summarize key aspects of CER definitions and provide examples highlighting the complementary nature of efficacy and CER studies in pulmonary, critical care, and sleep medicine. METHODS: An ad hoc working group of the American Thoracic Society with experience in clinical trials, health services research, quality improvement, and behavioral sciences in pulmonary, critical care, and sleep medicine was convened. The group used an iterative consensus process, including a review by American Thoracic Society committees and assemblies. RESULTS: The traditional efficacy paradigm relies on clinical trials with high internal validity to evaluate interventions in narrowly defined populations and in research settings. Efficacy studies address the question, "Can it work in optimal conditions?" The CER paradigm employs a wide range of study designs to understand the effects of interventions in clinical settings. CER studies address the question, "Does it work in practice?" The results of efficacy and CER studies may or may not agree. CER incorporates many attributes of outcomes research and health services research, while placing greater emphasis on meeting the expressed needs of nonresearcher stakeholders (e.g., patients, clinicians, and others). CONCLUSIONS: CER complements traditional efficacy research by placing greater emphasis on the effects of interventions in practice, and developing evidence to address the needs of the many stakeholders involved in health care decisions. Stakeholder engagement is an important component of CER.
Authors: James Dean Sandham; Russell Douglas Hull; Rollin Frederick Brant; Linda Knox; Graham Frederick Pineo; Christopher J Doig; Denny P Laporta; Sidney Viner; Louise Passerini; Hugh Devitt; Ann Kirby; Michael Jacka Journal: N Engl J Med Date: 2003-01-02 Impact factor: 91.245
Authors: Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin Journal: N Engl J Med Date: 2006-05-21 Impact factor: 91.245
Authors: Karen K Y Koo; Jack C J Sun; Qi Zhou; Gordan Guyatt; Deborah J Cook; Stephen D Walter; Maureen O Meade Journal: Crit Care Med Date: 2011-07 Impact factor: 7.598
Authors: Cynthia Binanay; Robert M Califf; Vic Hasselblad; Christopher M O'Connor; Monica R Shah; George Sopko; Lynne W Stevenson; Gary S Francis; Carl V Leier; Leslie W Miller Journal: JAMA Date: 2005-10-05 Impact factor: 56.272
Authors: David Price; Stanley D Musgrave; Lee Shepstone; Elizabeth V Hillyer; Erika J Sims; Richard F T Gilbert; Elizabeth F Juniper; Jon G Ayres; Linda Kemp; Annie Blyth; Edward C F Wilson; Stephanie Wolfe; Daryl Freeman; H Miranda Mugford; Jamie Murdoch; Ian Harvey Journal: N Engl J Med Date: 2011-05-05 Impact factor: 91.245
Authors: Christopher G Slatore; Nanda Horeweg; James R Jett; David E Midthun; Charles A Powell; Renda Soylemez Wiener; Juan P Wisnivesky; Michael K Gould Journal: Am J Respir Crit Care Med Date: 2015-08-15 Impact factor: 21.405
Authors: Jeremy M Kahn; Billie S Davis; Tri Q Le; Jonathan G Yabes; Chung-Chou H Chang; Derek C Angus Journal: J Crit Care Date: 2018-03-23 Impact factor: 3.425
Authors: Curtis H Weiss; Jerry A Krishnan; David H Au; Bruce G Bender; Shannon S Carson; Adithya Cattamanchi; Michelle M Cloutier; Colin R Cooke; Karen Erickson; Maureen George; Joe K Gerald; Lynn B Gerald; Christopher H Goss; Michael K Gould; Robert Hyzy; Jeremy M Kahn; Brian S Mittman; Erika M Mosesón; Richard A Mularski; Sairam Parthasarathy; Sanjay R Patel; Cynthia S Rand; Nancy S Redeker; Theodore F Reiss; Kristin A Riekert; Gordon D Rubenfeld; Judith A Tate; Kevin C Wilson; Carey C Thomson Journal: Am J Respir Crit Care Med Date: 2016-10-15 Impact factor: 21.405
Authors: Victor D Dinglas; Caroline M Chessare; Wesley E Davis; Ann Parker; Lisa Aronson Friedman; Elizabeth Colantuoni; Clifton O Bingham; Alison E Turnbull; Dale M Needham Journal: Thorax Date: 2017-07-29 Impact factor: 9.139
Authors: Dale M Needham; Kristin A Sepulveda; Victor D Dinglas; Caroline M Chessare; Lisa Aronson Friedman; Clifton O Bingham; Alison E Turnbull Journal: Am J Respir Crit Care Med Date: 2017-11-01 Impact factor: 21.405
Authors: Jerry A Krishnan; Molly A Martin; Cortland Lohff; Giselle S Mosnaim; Helen Margellos-Anast; Julie A DeLisa; Kate McMahon; Kim Erwin; Leslie S Zun; Michael L Berbaum; Michael McDermott; Nina E Bracken; Rajesh Kumar; S Margaret Paik; Sharmilee M Nyenhuis; Stacy Ignoffo; Valerie G Press; Zachary E Pittsenbarger; Trevonne M Thompson Journal: Contemp Clin Trials Date: 2017-03-31 Impact factor: 2.226
Authors: Alison E Turnbull; Anahita Rabiee; Wesley E Davis; Mohamed Farhan Nasser; Venkat Reddy Venna; Rohini Lolitha; Ramona O Hopkins; O Joseph Bienvenu; Karen A Robinson; Dale M Needham Journal: Crit Care Med Date: 2016-07 Impact factor: 7.598